Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy
{{output}}
Aberrant glucose utilization is a hallmark of malignant cells and represents an attractive target for anticancer intervention. Here, we describe development of Medical Fluorophore 48 (MF48), a synthesized compound that simultaneously inhibits glucose metabolis... ...